- Home
- PRLD vs RSF Comparison
PRLD vs RSF Comparison
Compare PRLD & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- RSF
- Stock Information
- Founded
- PRLD 2016
- RSF 2016
- Country
- PRLD United States
- RSF United States
- Employees
- PRLD N/A
- RSF N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- RSF Investment Managers
- Sector
- PRLD Health Care
- RSF Finance
- Exchange
- PRLD Nasdaq
- RSF Nasdaq
- Market Cap
- PRLD 69.1M
- RSF 62.5M
- IPO Year
- PRLD 2020
- RSF N/A
- Fundamental
- Price
- PRLD $1.42
- RSF $14.80
- Analyst Decision
- PRLD Strong Buy
- RSF
- Analyst Count
- PRLD 3
- RSF 0
- Target Price
- PRLD $4.00
- RSF N/A
- AVG Volume (30 Days)
- PRLD 290.5K
- RSF 11.8K
- Earning Date
- PRLD 11-05-2025
- RSF 01-01-0001
- Dividend Yield
- PRLD N/A
- RSF 10.61%
- EPS Growth
- PRLD N/A
- RSF N/A
- EPS
- PRLD N/A
- RSF N/A
- Revenue
- PRLD $7,000,000.00
- RSF N/A
- Revenue This Year
- PRLD N/A
- RSF N/A
- Revenue Next Year
- PRLD N/A
- RSF N/A
- P/E Ratio
- PRLD N/A
- RSF N/A
- Revenue Growth
- PRLD N/A
- RSF N/A
- 52 Week Low
- PRLD $0.61
- RSF $14.81
- 52 Week High
- PRLD $2.08
- RSF $16.23
- Technical
- Relative Strength Index (RSI)
- PRLD 60.29
- RSF N/A
- Support Level
- PRLD $1.33
- RSF N/A
- Resistance Level
- PRLD $1.63
- RSF N/A
- Average True Range (ATR)
- PRLD 0.18
- RSF 0.00
- MACD
- PRLD 0.01
- RSF 0.00
- Stochastic Oscillator
- PRLD 49.42
- RSF 0.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.